Opendata, web and dolomites

BodyDMI SIGNED

Development of deuterium metabolic imaging to map body biochemistry with MRI

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 BodyDMI project word cloud

Explore the words cloud of the BodyDMI project. It provides you a very rough idea of what is the project "BodyDMI" about.

administration    oral    metabolic    feasibility    map    cancer    linked    dmi    mri    coil    disturbances    attributed    valorized    designs    300    uncompromised    mhz    operation    resonance    proof    hepatic    idea    therapies    deuterium    window    image    metabolism    successful    patients    relies    designed    drug    lipid    lagged    imaging    dramatic    combined    humans    labeled    45    carbohydrate    efficacy    morphological    2016    scanner    biochemistry    session    ultra    techniques    arguably    obesity    ed    scan    dual    loop    spectroscopic    dynamic    global    treatment    diabetes    commercial    stage    dynamically    tesla    chemical    dipole    3d    outperformed    01    mcube    lack    setup    completion    transparent    mode    2017    coils    besides    sensitivity    compounds    toxicity    hydrogen    epidemic    innovation    magnetic    detect    complement    operates    body    frequency    diseases    clinical    opens    invasive    organ    outperforms    optimal    array    earlier    fet   

Project "BodyDMI" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAIR MEDISCH CENTRUM UTRECHT 

Organization address
address: HEIDELBERGLAAN 100
city: UTRECHT
postcode: 3584 CX
website: www.umcutrecht.nl

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 100˙000 €
 EC max contribution 100˙000 € (100%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-2018-2019-2020-03
 Funding Scheme CSA
 Starting year 2019
 Duration (year-month-day) from 2019-06-01   to  2020-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAIR MEDISCH CENTRUM UTRECHT NL (UTRECHT) coordinator 81˙250.00
2    WAVETRONICA BV NL (UTRECHT) participant 18˙750.00
3    MR COILS BV NL (ZALTBOMMEL) participant 0.00

Map

 Project objective

The global obesity epidemic has resulted in a dramatic rise in metabolic diseases and the development of effective therapies has greatly lagged behind. This could arguably be attributed to a lack of non-invasive (imaging) techniques to characterize disturbances in metabolic pathways. We will investigate the use of dynamic deuterium metabolic imaging (DMI) to dynamically map body biochemistry in humans in 3D imaging mode. DMI relies on deuterium magnetic resonance spectroscopic imaging combined with oral administration of deuterium-labeled compounds.

The innovation idea is linked to the MCUBE project of FET-OPEN-01-2016-2017. Here a dual-dipole coil was designed for hydrogen MRI at 7 tesla (300 MHz), which outperformed the state-of-the-art setup of the loop-dipole coil for MRI. The new design is transparent to loop designs, meaning that the setup can be combined with loop coils, which are known to be the optimal setup for low frequency operation. So for DMI, which operates at 45.7 MHz (low frequency) at 7 tesla, an MRI coil array can be designed that not only outperforms MRI, but also enables DMI at uncompromised sensitivity within the same scan session, which will complement the utilization of the MCUBE project.

The objectives of the project are: (1) Build and test a body DMI setup for a clinical ultra-high field 7 tesla MRI scanner; (2) demonstrate proof of concept to measure hepatic carbohydrate and lipid metabolism with DMI; and (3) apply DMI in a clinical feasibility study in type 2 diabetes patients. Upon successful completion of the project, DMI will be valorized by the commercial partners and embedded in clinical practice, which opens up a new window for drug studies to directly image their chemical efficacy. Besides its application in metabolic diseases, DMI has potential to detect organ failure, drug toxicity and effects of cancer treatment in a much earlier stage than morphological imaging.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BODYDMI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BODYDMI" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

BRIEFING (2018)

Bridging the FET Innovation Gap

Read More  

RSENSE (2020)

Revolutionizing disease and environmental detection with portable optoacoustic sensing

Read More  

ATEMPGRAD (2019)

Analysing Temperature Effects with a Mobile and Precise Gradient Device

Read More